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The validity of the concept of the molecular electrostatic . 
potential and its applicability in rationalizing drug-receptor inter-
actions are discussed on hand of examples covering the qualitative 
aspects. The computational methods are briefly reviewed with 
respect to economy and quality of results. 
INTRODUCTION 
Molecular recognition is the prerequisite for the organization and funct-
ioning of biological systems. From the point of view of the theoretical chemist 
the treatment of the recognition is in essence reduced to the calculation of 
the energy of interaction between two molecules or between the relevant parts 
of macromolecules, e.g. the recognition site of an enzyme and the reacting part 
. of the substrate. The entropy factor is usually not explicitely considered in 
this approach. For the understanding of the mechanism of recognition the ana-
lysis of the interaction energy into components such as the classical electro-
static, polarization, charge transfer, dispersion, etc. is importa:nt1. It is also 
helpful in the search for the molecular determinants of recognition that are 
needed in the design of molecules with predetermined properties. For the 
application of the full potential of the quantum methods developed in the study 
of intermolecular complexes some knowledge of the molecular structure is 
necessary. However, in one group of recognition phenomena the knowledge of 
the structure is lacking for one of the components of the complex. These are 
the receptors for hormones, neurotransmitters and drugs (we shall call them 
briefly ligands) involved in the regulation of various physiological processes. 
This fact throws the weight of the search of molecular determinants of recog-
nition entirely onto the side of the small molecules with known structure that 
are recognized (or not) by the receptor. The task is not trivial since molecules 
having similar characteristics with respect to receptor recognition may be of 
quite dissimilar chemical structure. Although the established procedures for 
the theoretical investigations of the interactions between molecules with known 
structure cannot be directly applied to ligand-receptor interactions the results 
obtained on the former are used in developing model representations of the 
latter from which the search for the molecular determinants of recognition 
starts. After Scrocco and Tomasi had revived2 the interest in the electrostatic 
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model of intermolecular interactions by demonstrating the parallels between 
the SCF energy and that arising from the unperturbed charges of interacting 
molecules the concept of the molecular electrostatic potential (MEP) is being 
increasingly used in biomolecular problems. For instance, it was applied in 
interpreting the reactivity of nucleic acids2,3 and to the description of enzyme 
inhibitor interactions4 . MEP appears promising6 as a molecular determinant of 
ligand recognition by receptors and the MEP maps are particularly inviting 
for the visual search of similarities between chemically diverse ligands. There 
are, however, several issues about the use of MEP in dealing with the ligand-
-receptor interactions. They range from the general question of the validity of 
the concept to the heuritsic value of the topographic features in the MEP 
maps and to the quantitative aspects of MEP features what is most relevant 
to drug design. We shall deal with these issues in the first part of this paper 
on hand of some examples. The need to compute the MEP of series of rather 
large molecules raises problems of computational economy vs. quality of the 
results due to the approximations used and this is the second issue we shall 
deal with. 
A. The validity of the electrostatic model has been demonstrated on 
numerous examples of complexes of small molecules, particularly those with 
hydrogen bonds where comparative calculations of the geometry and energy 
are feasible at the SCF leve12c, 6 • Although for ligands with strongly polar 
groups, e.g. the catecholamines, the first order electrostatic interactions with 
the receptor are likely to be important it is not certain that other types of 
interactions may be neglected. In the absence of hard proofs, adequate evidence 
can be obtained, for instance, from quantitative structure-activity relationships 
(QSAR) using as parameters appropriately selected features of the MEP. The 
side chain amino group of biogenic amines is well known as a primary point of 
attachment to receptors and, on the other hand, the MEP of simple amines 
was thoroughly examined as a reactivity index in protonation and hydrogen 
bondtng7• The obvious choice of the parameter to be correlated with the ligand-
-receptor dissociation constant was the value of the MEP at a determined point 
in the region of the nitrogen lone pair (VN). We have calculated V N from ab-
-initio wave functions of 11 amines representing the side chain of 35 fi-adren-
energic agonists8 for which biological data were available. The statistical 
evaluation has demonstrated that V N can explain more than 50 p . c. of the 
variance in affinity of these drugs for the ft-receptor. The inclusion of the 
MEP of phenyl substituents in the r egression analysis has improved the cor-
relation9 demonstrating the importance of the electrostatic forces for the li-
gand-receptor interaction, but obviously other contributions to the free energy 
of interaction are not negligible. This may be illustrated by the example 
of 2-phenyl-imino- and benzyl-imidaz.olidine type drugs that are important 
a -adrenergic agonists. Although they are likely to interact with the receptor 
primarily by electrostatic forces , the similarity of the dissociation constant 
(Ki) for the representatives shown in Figure 1 confronted with the character 
of the substituents intuitively suggests that the MEP could hardly determine 
the biological differences between them. Indeed, in the MEP's computed from 
MNDO wave functions for 23 representative molecules10 no feature was found 
that would rationalize the trends in K i. The MEP above the aromatic plane 
computed from the MNDO wave function for a test molecule (dopamine) in 
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Figure 1. Chemical structure of representative phenylimidazoline type adrenergic 
drugs with their pK values I : 2 (2,6-dimethylphenyl-imino)-imidazolidine; II: clonid-
ine, III: xylometazoline. 
the point charge approximation was quite similar to the one computed in the 
same approximation from the ab-initio ST0-3G function except for slightly 
smaller a,bsolute values. Amongst other parameters tested in QSAR the best 
correlation of pK; was found with the conformational entropy10• This is a very 
instructive case showing that the entropic factor may outweigh the differences 
in the enthalpic part of the free energy of association and be thus determining 
the differences between the members of a series of structurally related mo-
lecules. 
Arguments 'On statistical basis require sufficiently large sets of data. Ho-
wever, suitable biological data (e .g. consistent K; values) are scarce. Thus, in 
seeking good examples for the application of the MEP concept one is limited 
to rather qualitative considerations of the MEP concept for which molecules 
with pronounced differences in biological characteristics have to b e chosen and 
it is desirable to produce additional evidence for the MEP as the determinant 
of recognition. Weinstein et aL.11 have examined a small series of 5-hydroxy-
tryptamine congeners that are recognized by the serotonin receptor. These 
authors have introduced the electrostatic orientation vector12 as the molecular 
determinant of recognition. The vector is obtained by connecting the MEP 
minima above the substituted indole ring. Its direction depends upon the 
position of the substituents. These drugs are supposed to become first attached 
to the receptor by the side chain like other biogenic amines and interact sub-
sequently by stacking of the indole moiety with some aromatic amino acids of 
the receptor. This model was projected on hand of the known structures of 
indole complexes13 . The interaction energy of the 5-hydroxytryptamine con-
geners with the receptor depends on the direction of their orientation vector 
relative to the electric field of the receptor presented by the model molecule, 
the imidazolium cation. Thus it was possible to explain the extreme differences 
in serotoninergic activity between 5- and 6-hydroxytryptamine and some other 
congeners in between. The analysis of the interaction energy with the receptor 
modelling imidazolium cation demonstrated the dominance of the electrostatic 
component14• 
The majority of applications of the MEP concept to pharmacological problems 
are limited to the demonstration of topological similarities between molecules 
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recognized by a certain type of receptor and differences between these and 
the molecules that are rejected by the receptor. For example, apomorphine 
may be taken as representative of catecholamine type molecules recognized by 
the dopamine receptor. Its rigidity is instrumental in resolving the problems 
of steric nature15. The molecular determinants of recognition deduced from the 
examination of a series of dopamine congeners are the aliphatic nitrogen with 
its negative MEP and the negative MEP region above the aromatic part which 
must be in proper spatial relations15 as illustrated in Figure 2. Ergolene and 
some of its partial structures are also recognized by the dopamine receptor 
although they are different in chemical structure from the catecholamines. 
However, there is a definite topographical similarity between the MEP above 
the aromatic plane of both types of molecules. The MEP's in this study were 
obtained by the full ab-initio (ST0-3G basis) procedure. To demonstrate the 
congruence of the MEP of catecholamine type ligands and those ·of the ergolene 
type the aliphatic nitrogen was taken as reference and the steric requirements 
of the dopamine receptor were properly observed. Figure 3 shows the con-
gruence of the skeletons of apomorphine and ergolene, and the matc}i.ing of 
the deepest negative region above the 11-0H group with that above the indole 
ring, respectively. The zero contours are also similar. In contrast, there is no 
acceptable congruence of the apomorphine and 2-azaergolene skeletons and the 
zero contours are almost perpendicular (Figure 4) . This may explain the inact-
ivity of the latter. The details of this work that include also partial ergolene 
structures will be published elsewhere16• 
The topographical congruence of the MEP of a prototype molecule with 
those of chemically dissimilar molecules as evidence that electrostatic inter-
actions dominate the recognition can be corroborated by the exclusion of other 
possible determinants, e.g. reactivity indices based on HOMO and LUMO 
characteristics16•17. However, MEP based predictions of activity are the best and, 
from the practical point of view, the most useful evidence for the soundness 
of the MEP concept5b,c. 
B. The necessity of computing MEP's for a series of molecules in the size 
of 20 or more atoms requires economical procedures. However, this raises pro-
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H 
Figure 3. Superposition of apomorphine (full treat) and ergolene (dashed) skeletons 
and MEPs (deepest potential region and zero contour only, 1.6 A above the aromatic 
plane. 
H 
' ' .... .... 
Figure 4. Superposition of apomorphine and 2-azaergolene skeletons and MEPs (as 
in Figure 3) . 
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blems of the adequatness of the computed MEP's. To envisage the problems 
consider Eq. (1) defining the electrostatic potential V at point P: 
N 
V (P) = L 
i= 1 
(1) 
where Q (r') is the electron density, ri are atomic coordinates and z; atomic 
numbers. It is solved in two steps the first of which is the calculation of the 
density matrix from the molecular wave function. Assuming that a standard 
ab-initio method18,19 with Gaussian functions as basis set was used to solve 
Roothan equations20, we have to calculate in the second step the integrals over 
all Gaussian functions, i. e. atomic orbitals for each position of the probing 
charge (usually + e) for which we need to know the electrostatic interaction 
energy with the molecule. For one point in space this is not much of a computer 
time consuming work, but for a decent graphic representation of the MEP of a 
twenty atom molecule about ten thousand points are nedded. This number 
can be reduced by some interpolation method21 to about 300. Further computer 
time can be saved in the calculation of electrostatic attraction integrals over 
the atomic orbitals. These integrals when evaluated in the cartesian coordinate 
system split into three one dimensional integrals over each coordinate and in 
an additional integration which is related to the error function used in statistics. 
The error function integral cannot be solved analyticaly and therefore it is 
approximated by a series. Alternatively, it may be expressed by a quotient of 
two polynoms fitted to give accurate results. This latter method reduces the 
computer time to about five to ten times in comparison with the series ap-
proximation22. Since the basis functions are the same for all points in which 
the MEP has to be calculated one can put in tables many values for all the 
combinations of atomic orbitals. These tables are stored in the main computer 
memory during the calculation for all points. With these improvements a 
program was developed in our laboratory that allows computer time saving 
by a factor of twenty in comparison with Polyatom19. 
An often discussed point is the quality of the wave function. Within the 
ab initio scheme, the influence of the basis set upon the resulting MEP has 
been analyzed and the efficiency of pseudopotential calculation demonstrated23• 
The comparison for various basis sets shows no significant differences . The 
agreement for some basis sets with experimental data is still obtained by 
chance and an ab initio calculated MEP gives only qualitative results so that 
the minimal basis set is quite satisfactory24,2s. 
The most controversial issue is the use of semiempirical methods. The 
calculation of glr integrals from zero differential overlap schemes results in 
differences both in the position and in the depth of the MEP minima in the 
region of lone electron pairs with respect to the ab initio calculated ones. A 
grave defect resulting from ZDO schemes is the sign of the MEP above the 
aromatic ring which is positive instead of negative. Improvements were obtained 
by calculating the exact nuclear attraction26 to s orbitals in Eq. (1) or using 
empirical values and by deorthogopalizing the density matrix. Since all the 
attraction integrals in the summation of Eq. (1) have to be calculated in the 
latter procedure this requires more computer time. The results are comparable 
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to the non-empirically obtained ones for the MEP in the plane of substituted 
aromatics, but the MEP above the plane is still positive27 • 
An often used group of approximations are point charge methods. Total 
atomic charges obtained from the Mullikan population analysis2B may be used 
in the evaluation of MEP by simple summation: 
(2) 
where N is the number of atoms, qi is the charge, zi is the atomic number and 
ri are the atomic coordinates. The values of the MEP at distance less than 1.5 A 
from the nuclei are unreliable in the point charge approximation and Eq. (2) 
cannot be used for the calculation of in plane lone pair regions. The function 
llr has no repulsive character by itself and the atoms with opposite character 
of the one studied are too far for having any influence. However, the MEP over 
extended surfaces is quite comparable to the one obtained in the whole.scheme. 
This is illustrated by Figure 5 with the MEP of 3-methylindole 1.6 A above the 
aromatic plane. 
Figure 5. MEP maps (contours in a. u.) of 3-methylimidmole 1.6 A above the aromatic 
plane computed from the ab initio ST0-3G wave function. (a) - full integral evalua-
tion, (b) - point charge method. 
Tomasi and coworkers have made a further step in simplifying the evalua-
tion of the MEP by which a previous evaluation of the wave function is avoided. 
The procedure is based on transferable group contributions to the MEP. The 
electrostatic potentials of characteristic electron pairs of o and re bonded groups 
as well as of larger groups built from them do not seem to vary strongly from 
molecule to molecule and thus the sum of the model pair contributions is a 
reasonable approximation to the SCF calculated MEP29 . In a further elaborat-
ion 30 of the concept of transferable group contributions the localized orbitals 
are modelled by point charges displaced from the electronic charge center of 
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the orbital. The direction of the displacement depends on the character (o or ;r) 
of the orbital. For lone pairs the charge is placed at the orbital center. In 
aromatic systems o and n: bonds are treated separately31• Comparisons with the 
SCF calculated MEPs of simple molecules are promising to make the transfer-
able group concept a useful and inexpensive tool for the investigation of react-
ion properties of large molecules, at least on a qualitative level. The results 
seem to be in certain respects even superior to those obtained by the simple 
summation over total atomic charges30. 
The final point concerns the MEP of large molecules for which even the 
nonempirical schemes are not practicable for calculating the density matrix. 
The only way to overcome this is to break down the system into smaller sub-
units for which the wave function and the MEP can be calculated. The free 
valencies appearing at the cuts are absorbed by fictitious hydrogens and the 
MEP of the whole system is obtained by the superposition of the subunits:i2 • 
This leads obviously to a perturbed MEP of the macromolecule, but Pullman 
et al. have shown33•34 that perturbations are generally small and confined to 
the vicinity of the junctions. The superposition method can be improved by 
using localized molecular orbitals and their expansion to multicentered mul-
tipoles. The ab initio SCF wave function is first calculated and is then localized 
with the Boys technique35. 
Next, a single center multipole expansion is performed for each occupied 
LMO. The choice of the centroids of the LMO for the center of the multipole 
e~ansion leads to a - 2 (in atomic units) for a monopole and zero for a dipole. 
Truncating the multipole expansion at octapoles yields very accurate results in 
comparison to ab-initio ones32. Since the values for the monopoles in the case of 
fictitious hydrogenated subunits and of the subunit in the real supermolecule 
are the same (equal to - 2) and for the dipole (equal to zero), the error in 
superposition is reduced. With a carefully chosen subdivision of the macro-
molecule the superposition error can be even more reduced. 
CONCLUSION 
There are now quite a few examples of successful applications of the 
concept of MEP in the search of molecular determinants of receptor recognition. 
Particular features in the MEP such as its value at a defined point can be used 
also in quantitative structure-activity relationships. In qualitative applications 
which are based on the similarity of the MEP a possible development is in the 
direction of removing subjectivity in the judgement of similarity by introducing 
some metrics. From the computational point of view the defects due to various 
approximations are by now well known so that the most efficient and yet suf-
ficiently accurate method of computing MEP may be selected. Concerning the 
biomolecular problems to which the concept of MEP may be applied, it has to 
be borne in mind that the electrostatic component of interaction energy is 
not necessarily dominating in the recognition and, moreover, that recognition 
is only one link in the chain of events upon which the biological activity is 
depending. Therefore, a carefull judgement of the problem is advisable before 
embarking in lengthy computations. 
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SAZETAK 
Molekulski elektrostatski potencijal kao odlucujuci faktor u odredivanju 
prepoznavanja receptora i lijeka 
Duilan Hadzi, Milan Hodoscek, Darko Kocjan, Tomaz Solmajer i Franc Avbelj 
Razmatrana je primjena koncepta molekulskoga elektrostatskog potencijala u 
odredivanju i racionalizaciji interakcija izmedu receptora i lijekova. Diskutirani su 
njegovi kvalitativni i kvantitativni aspekti. Dan je kratak opis odgovarnjucih nume-
rickih postupaka s posebnim osvrtom na ekonomiju racuna i kvalitet rezultata. 
